Affiliation:
1. South Ural State Medical University
Abstract
Introduction. The relevance of the search for effective methods of treatment of various forms of laryngitis is associated with a high frequency of occurrence, which has a certain seasonality. Optimization of treatment tactics is dictated by the variability of etiopathogenetic mechanisms, with a certain similarity of clinical symptoms, and the reactivity of the mucous membrane to inflammation. The methods of treatment described in the literature are diverse and lead to the search for therapeutic adjustments.Objective. To increase the effectiveness of the treatment of various forms of acute laryngitis using the multicomponent drug Homeovox® in complex therapy.Materials and methods. A randomized simple controlled clinical trial involved 132 patients with acute laryngitis of various etiologies. Efficacy in terms of recovery time and safety were evaluated in two parallel groups: group 1, patients with acute laryngitis on the background of acute respiratory viral infection and group 2, patients with acute laryngitis on the background of a new strain “omicron”, COVID-19. In the course of treatment, both groups were divided into 2 subgroups: 1st – patients who received standard conservative therapy and the 2nd – persons who, in addition to complex therapy, received the drug – Homeovox®. Treatment results were assessed using the VAS scale, quality of life was assessed using the SNOT-22 questionnaire, cognitive functions were evaluated using standard psychological tests.Results and discussion. The use of the multicomponent preparation Homeovox®, which has multidirectional mechanisms of action in the complex therapy of patients with various forms of acute laryngitis, improved clinical symptoms, quality of life and recovery time. Good portability, high efficiency and safety were noted.Conclusions. The use of the preparation Homeovox® in the treatment of various forms of acute laryngitis has demonstrated its ability to quickly stop the symptoms of the disease and significantly improve the quality of life of patients.
Reference51 articles.
1. Stachler R.J., Francis D.O., Schwartz S.R., Damask C.C., Digoy G.P., Krouse H.J. et al. Clinical Practice Guideline: Hoarseness (Dysphonia) (Update). Otolaryngol – Head Neck Surg. 2018;158(1 Suppl.):1–42. https://doi.org/10.1177/0194599817751030.
2. Baranov A.A., Namazova- Baranova L.S., Lobzin Yu.V., Uskov A.N., Tatochenko V.K., Bakradze M.D. et al. Federal Clinical Guidelines for the Provision of Medical Care to Children with Acute Respiratory Viral Infection (Acute Nasopharyngitis). Moscow; 2015. 12 p. (In Russ.) Available at: https://minzdrav.gov.ru/ministry/61/5/1/federalnye-klinicheskierekomendatsii-po-okazaniyu-meditsinskoy-pomoschi-detyam-s-orvi.Egorov V.I., Kozarenko A.V. Modern approach to the treatment of acute viral rhinosinusitis. Almanac of Clinical Medicine. 2016;44(7 Suppl.). (In Russ.)
3. Selkova E.P., Kalyuzhin O.V. SARS and influenza. Help for the practitioner. Moscow: MIA; 2015. 222 p. (In Russ.) Available at: https://search.rsl.ru/ru/record/01008121442.
4. Chow A.W., Benninger M.S., Brook I., Brozek J., Goldstein E., Hicks L. et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8):72–112. https://doi. org/10.1093/cid/cir1043.
5. Korkmazov M.Yu., Kornova N.V., Chin’kov N.A. The nature of cephalgia in acute and chronic sinusitis, their impact on the quality of life. Rossiyskaya Otorinolaringologiya. 2009;2(39):96–101. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=14565167.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献